Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

Nektar’s plunge is a buying opportunity–so I’m adding more to my Volatility Portfolio

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

Sangamo gets RMAT status for its hemophilia gene therapy

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

Adding Nektar call options to my Volatility Portfolio–again

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

Nektar Therapeutics bumps along ahead of August FDA action on new non-addictive opioid

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200